CoChat

Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax

Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., Tjitra, E., Anstey, N. M., Price, R. N. · 2008 · Antimicrobial Agents and Chemotherapy
Cited by 118

The DOI matches its Crossref record.

Abstract

In Papua, Indonesia, the antimalarial susceptibility of Plasmodium vivax ( n = 216) and P. falciparum ( n = 277) was assessed using a modified schizont maturation assay for chloroquine, amodiaquine, artesunate, lumefantrine, mefloquine, and piperaquine. The most effective antimalarial against P. vivax and P. falciparum was artesunate, with geometric mean 50% inhibitory concentrations (IC 50 s) (95% confidence intervals [CI]) of 1.31 nM (1.07 to 1.59) and 0.64 nM (0.53 to 0.79), respectively. In contrast, the geometric mean chloroquine IC 50 for P. vivax was 295 nM (227 to 384) compared to only 47.4 nM (42.2 to 53.3) for P. falciparum . Two factors were found to significantly influence the in vitro drug response of P. vivax : the initial stage of the parasite and the duration of the assay. Isolates of P. vivax initially at the trophozoite stage had significantly higher chloroquine IC 50 s (478 nM [95% CI, 316 to 722]) than those initially at the ring stage (84.7 nM [95% CI, 45.7 to 157]; P < 0.001). Synchronous isolates of P. vivax and P. falciparum which reached the target of 40% schizonts in the control wells within 30 h had significantly higher geometric mean chloroquine IC 50 s (435 nM [95% CI, 169 to 1,118] and 55.9 nM [95% CI, 48 to 64.9], respectively) than isolates that took more than 30 h (39.9 nM [14.6 to 110.4] and 36.9 nM [31.2 to 43.7]; P < 0.005). The results demonstrate the marked stage-specific activity of chloroquine with P. vivax and suggest that susceptibility to chloroquine may be associated with variable growth rates. These findings have important implications for the phenotypic and downstream genetic characterization of P. vivax .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.01334-07

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 25

  1. 10.4269/ajtmh.1991.44.547 · DOI · Paper page
  2. 10.4269/ajtmh.1997.56.621 · DOI · Paper page
  3. 10.1086/512242 · DOI · Paper page
  4. 10.4269/ajtmh.2004.70.395 · DOI
  5. 10.1128/AAC.01385-06 · doi:10.1128/aac.01385-06
  6. Fryauff, D. J., S. Tuti, A. Mardi, S. Masbar, R. Patipelohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg.59:513-518. · doi:10.4269/ajtmh.1998.59.513
  7. 10.1016/0035-9203(84)90145-7 · doi:10.1016/0035-9203(84)90145-7
  8. 10.1016/0092-8674(92)90642-P · DOI · Paper page
  9. Hamedi, Y., M. Nateghpour, B. Soonthornsata, P. Tan-ariya, S. Kojima, D. Chindanond, and S. Looareesuwan. 2003. Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand. Trans. R. Soc. Trop. Med. Hyg.97:435-437. · doi:10.1016/s0035-9203(03)90080-0
  10. 10.1086/512241 · DOI · Paper page
  11. 10.1016/j.exppara.2006.02.006 · doi:10.1016/j.exppara.2006.02.006
  12. Lux, D., S. Prajakwong, H. Kollaritsch, G. Wernsdorfer, and W. H. Wernsdorfer. 2003. In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand. Wien. Klin. Wochenschr.115(Suppl. 3):50-54.
  13. 10.4269/ajtmh.1974.23.1007 · doi:10.4269/ajtmh.1974.23.1007
  14. 10.1128/AAC.44.6.1680-1685.2000 · DOI · Paper page
  15. 10.1016/S0140-6736(07)60160-3 · DOI · Paper page
  16. 10.1016/j.trstmh.2006.06.008 · DOI · Paper page
  17. 10.1016/j.ijpara.2007.05.003 · DOI
  18. 10.1016/S0140-6736(89)91792-3 · DOI · Paper page
  19. 10.1128/AAC.47.1.170-173.2003 · DOI
  20. 10.4269/ajtmh.2001.65.90 · doi:10.4269/ajtmh.2001.65.90
  21. 10.4269/ajtmh.2003.68.416 · DOI
  22. 10.1371/journal.pone.0001089 · DOI · Paper page
  23. 10.1016/S0001-706X(02)00056-6 · doi:10.1016/s0001-706x(02)00056-6
  24. 10.1016/j.trstmh.2005.04.024 · DOI
  25. 10.1111/j.1550-7408.1983.tb05336.x · doi:10.1111/j.1550-7408.1983.tb05336.x

Cited by

Metadata

Authors
Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., Tjitra, E., Anstey, N. M., & Price, R. N.
Affiliations
  • International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
  • Menzies School of Health Research—National Institute of Health Research and Development Malaria Research Program, Timika, Indonesia
  • National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
  • Mitra Masyarakat Hospital, Timika, Indonesia
  • Department of Drug Resistance and Diagnostics, Australian Army Malaria Institute, Brisbane, Australia
Venue
Antimicrobial Agents and Chemotherapy
Published
2008-03
Volume
52
Issue
3
Pages
1040-1045
ISSN
  • 0066-4804
  • 1098-6596
Cited by
118
References
0
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.